Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)Ming‐Tao Wen, Di Luo, Gang Li et al.|Frontiers in Pharmacology|2024Cited by 29
Comparing musculoskeletal and connective tissue disorder risks of teriparatide and abaloparatide in osteoporosis: an analysis based on FDA adverse event reporting system (FAERS)Ming‐Tao Wen, Gang Li, Di Luo et al.|Expert Opinion on Drug Safety|2024Cited by 6
Safety comparisons among different subcutaneous anticoagulants for venous thromboembolism using FDA adverse event reporting systemBo‐Wen Lu, Gang Li, Yuqi Guo et al.|Scientific Reports|2025Cited by 3